Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Conditions: Metastatic Prostate Cancer; Therapy, Directly Observed Interventions: Procedure: Cytoreductive prostatectomy or brachytherapy; Drug: ADT+second-generation antiandrogens ± chemotherapy Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials